Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TI... Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using our Co-Stimulatory Antigen Receptor, or CoStAR, platform. The company's lead product candidate, ITIL-168, is an autologous TIL therapy that it is initially developing for the treatment of PD-1-inhibitor relapsed or refractory advanced melanoma. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -5 | -23.2558139535 | 21.5 | 22.63 | 16.08 | 112102 | 18.13473257 | CS |
| 4 | -4.58 | -21.7267552182 | 21.08 | 25.8 | 16.08 | 93840 | 21.03747381 | CS |
| 12 | -5.51 | -25.0340754203 | 22.01 | 27.6916 | 16.08 | 89704 | 21.50870672 | CS |
| 26 | -5.203 | -23.9736441967 | 21.703 | 92 | 16.08 | 194899 | 46.00925625 | CS |
| 52 | 4.9 | 42.2413793103 | 11.6 | 92 | 9.62 | 110062 | 42.04918741 | CS |
| 156 | -168.1 | -91.0617551463 | 184.6 | 246.4 | 6.07 | 438283 | 42.68653692 | CS |
| 260 | -63.5 | -79.375 | 80 | 589.8 | 6.07 | 381122 | 113.71929175 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
